UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lessened by Evercore Wealth Management LLC

Evercore Wealth Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 0.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 378,700 shares of the healthcare conglomerate’s stock after selling 1,743 shares during the quarter. UnitedHealth Group makes up 3.4% of Evercore Wealth Management LLC’s investment portfolio, making the stock its 6th largest position. Evercore Wealth Management LLC’s holdings in UnitedHealth Group were worth $193,126,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 1.4% during the first quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock valued at $41,119,347,000 after buying an additional 1,147,051 shares during the period. State Street Corp boosted its stake in UnitedHealth Group by 1.6% during the first quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock worth $23,598,745,000 after acquiring an additional 714,903 shares in the last quarter. Capital International Investors boosted its stake in UnitedHealth Group by 4.3% during the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after acquiring an additional 790,219 shares in the last quarter. Geode Capital Management LLC boosted its stake in UnitedHealth Group by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock worth $7,821,210,000 after acquiring an additional 189,864 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its stake in UnitedHealth Group by 2.4% during the fourth quarter. Alliancebernstein L.P. now owns 11,015,163 shares of the healthcare conglomerate’s stock worth $5,531,154,000 after acquiring an additional 257,910 shares in the last quarter. Hedge funds and other institutional investors own 87.25% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares in the company, valued at $4,043,896. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares in the company, valued at $4,043,896. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. Over the last quarter, insiders sold 140,324 shares of company stock worth $75,086,185. 0.40% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $531.25 on Tuesday. The firm has a fifty day moving average price of $528.73 and a 200-day moving average price of $510.59. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The stock has a market cap of $496.92 billion, a PE ratio of 27.74, a price-to-earnings-growth ratio of 1.64 and a beta of 0.76. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The firm had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period in the prior year, the company posted $4.70 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Monday, September 12th will be given a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.24%. UnitedHealth Group’s dividend payout ratio is 34.46%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Loop Capital began coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 target price on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research note on Thursday, September 8th. Mizuho boosted their price objective on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Finally, Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.